Tags |
|
|
Links |
|
|
E-Folder - List Building - Why I Think of List Building as Traffic Leverage I
I think that we all know that the money that we make online on t
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
he long run is simply a function of some sort of the total amoun
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
of traffic that we send to our website, on a regular basis. Now
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
, if I were to send 100 visitors to my website every single day,
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
through the course of the month, then I would have 3000 unique v
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
sitors to my website every single month.
Let's just think about
Let's just think about
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
that day, we got 100 visitors to my website, and let's just say
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
that I have a product that converts on some average basis, 1 %,
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
aybe even 2%, let's call it 1%, let's make it nice and easy. At
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
that rate, I'm going to make 1 sale a day every day of the month
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
, I'm going to have 30 sales that month.
Now if instead of send
Now if instead of send
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
ng all of those unique visitors directly to a sales page and hop
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
ing that they purchase without ever having an opportunity to get
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
to know me, instead I give them an opportunity to get to know me
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
I offer them some kind of a free gift, I offer them a free E-co
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
urse, or a few free lessons on something, or just an opportunity
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
to join my E-zine or my E-newsletter or whatever you call whatev
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
r you're mailing out, and so I add them to that list and then th
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
ey get to know me.
They get to kind of believe me, they get to
They get to kind of believe me, they get to
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
rust me, they tested me out, they downloaded a free book of mine
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.e-folder.org.ua/article/71177/e-folder-List-Building--Why-I-Think-of-List-Building-as-Traffic-Leverage-I.html">List Building - Why I Think of List Building as Traffic Leverage I</a>
BB link (for phorums):
[url=http://www.e-folder.org.ua/article/71177/e-folder-List-Building--Why-I-Think-of-List-Building-as-Traffic-Leverage-I.html]List Building - Why I Think of List Building as Traffic Leverage I[/url]
Related Articles:
Temporary Medical Staffing Agency: Start-Up Costs
Communicating Boundaries to Tame Hostile Co-Workers, Customers and Bosses
It's In The List! That's Where It Is!
Bookmark it:
|